US Patent Issued to CytomX Therapeutics on Nov. 4 for "Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,017, issued on Nov. 4, was assigned to CytomX Therapeutics Inc. (South San Francisco, Calif.).

"Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof" was invented by Leila Marie Boustany (Redwood City, Calif.), Sherry L. La Porte (San Francisco), Bryan A. Irving (Woodside, Calif.) and Jeanne Grace Flandez (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein antibodies, activatable antibodies (AAs), bispecific antibodies, and bispecific activatable antibodies (BAAs). Also provided herein are methods of making and methods of use of these antibodies, AAs, b...